Found 10 results
Filters: Keyword is Idiopathic Pulmonary Fibrosis  [Clear All Filters]
Huang Y, Ma S-F, Espindola MS, Vij R, Oldham JM, Huffnagle GB, Erb-Downward JR, Flaherty KR, Moore BB, White ES et al..  2017.  Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.. Am J Respir Crit Care Med. 196(2):208-219.
Huang Y, Ma S-F, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, Strek ME, White SR, D Hogarth K, Sandbo NK et al..  2015.  A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.. BMC Pulm Med. 15:147.
Han MLK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, Moore BB, White ES, Flaherty KR, Huffnagle GB et al..  2014.  Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.. Lancet Respir Med. 2(7):548-56.
Huang LShuang, Mathew B, Li H, Zhao Y, Ma S-F, Noth I, Reddy SP, Harijith A, Usatyuk PV, Berdyshev EV et al..  2014.  The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.. Am J Respir Crit Care Med. 189(11):1402-15.
Peljto AL, Zhang Y, Fingerlin TE, Ma S-F, Garcia JGN, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE et al..  2013.  Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.. JAMA. 309(21):2232-9.
Noth I, Zhang Y, Ma S-F, Flores C, Barber M, Huang Y, Broderick SM, Wade MS, Hysi P, Scuirba J et al..  2013.  Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.. Lancet Respir Med. 1(4):309-317.
Huang LShuang, Fu P, Patel P, Harijith A, Sun T, Zhao Y, Garcia JGN, Chun J, Natarajan V.  2013.  Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.. Am J Respir Cell Mol Biol. 49(6):912-22.
Herazo-Maya JD, Noth I, Duncan SR, Kim S, Ma S-F, Tseng GC, Feingold E, Juan-Guardela BM, Richards TJ, Lussier Y et al..  2013.  Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.. Sci Transl Med. 5(205):205ra136.
Huang LShuang, Berdyshev E, Mathew B, Fu P, Gorshkova IA, He D, Ma W, Noth I, Ma S-F, Pendyala S et al..  2013.  Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.. FASEB J. 27(4):1749-60.
Zhang Y, Noth I, Garcia JGN, Kaminski N.  2011.  A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis.. N Engl J Med. 364(16):1576-7.